Article Text
Statistics from Altmetric.com
After diabetic retinopathy, retinal venous occlusion (RVO) is the most common cause of retinopathy leading to severe visual loss in all age groups. Generally, RVO is associated with systemic diseases with significant morbidity and mortality. The risk of RVO is increased in patients older than 65 years of age with systemic hypertension, cardiovascular disease, diabetes and obesity.1 Patients younger than 50 years of age may have other underlying conditions requiring appropriate investigation and treatment.2 3 We describe the development of central retinal venous occlusion (CRVO) and the efficacy of intravitreal triamcinolone acetonide injection (IVTA) for associated cystoid macular oedema (CME) in a young healthy woman after she was started on systemic multiple anti-androgen therapy for treatment of hirsutism.
Case report
A 24-year-old woman with a 4-month history of painless loss of vision and a diagnosis of CRVO in her left eye (OS) was referred for further evaluation and management. Her ocular history revealed squint surgery and amblyopia in her right eye (OD) since childhood. …
Footnotes
Competing interests: None declared.
Informed consent was obtained for publication of the person’s details in this report.